Epidemiology, Clinical Features, and Follow-Up of Patients With Syncope and a Positive Adenosine Triphosphate Test Result  by Perennes, Alain et al.
E
a
a
A
J
B
E
r
I
a
c
H
s
o
f
p
a
u
M
P
v
o
f
w
e
M
w
h
u
w
2
U
a
Journal of the American College of Cardiology Vol. 47, No. 3, 2006
© 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00
Ppidemiology, Clinical Features,
nd Follow-Up of Patients With Syncope
nd a Positive Adenosine Triphosphate Test Result
lain Perennes, MD, Marjaneh Fatemi, MD, Marie L. Borel, MD, Yves Lebras, Corinne L’Her, MD,
ean-Jacques Blanc, MD
rest, France
OBJECTIVES We sought to evaluate epidemiology, clinical features, and outcomes of patients with syncope
and an abnormal response to adenosine triphosphate (ATP).
BACKGROUND Syncope remains of unknown origin in almost 30% of the patients. Injection of ATP induces
in some of these patients, but not in control patients, a ventricular pause 6 s.
METHODS Patients with syncope of unknown origin had an intravenous injection of 20 mg of ATP. All
patients had a tilt test.
RESULTS Among 214 patients, 19 (8.9%) had a positive ATP test result. The proportion of positive test
results was higher (p  0.002) in women (14.3%) than in men (2.2%). Ten patients (4.7%)
had positive ATP and tilt test results. These patients (exclusively women) were older (p 
0.05) at the time of their fist syncope than the 67 patients with a negative ATP test result but
a positive tilt test result. There was a trend for these two test results to be correlated (p 
0.07). Side effects were of short duration and benign. The mean duration of pauses was longer
in women (p  0.009). During a mean period of 31  14 months, recurrences of syncope
were reported in 25% of patients.
CONCLUSIONS The ATP test is a safe test with an “abnormal” result in 10% of patients with syncope of
unknown origin. The profile of these patients is characteristic. (J Am Coll Cardiol 2006;47:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.044594–7) © 2006 by the American College of Cardiology Foundation
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iven after an extensive evaluation, the diagnosis of syncope
emains undetermined in approximately 30% of cases (1–4).
t has been suggested that induction of ventricular pause
fter intravenous injection of adenosine triphosphate (ATP)
ould unmask the cause of spontaneous syncope (5,6).
owever, these data are based on a limited number of
urveys published by two groups (5–7). The main objectives
f the present study were to evaluate epidemiology, clinical
eatures, and outcomes of patients with long ventricular
auses during ATP injection. The secondary goals were to
nalyze the safety of the test and its relationship with head
p tilt test (HUT).
ETHODS
atient selection. Patients admitted consecutively for in-
estigation of syncope diagnosed according to the guidelines
f the European Society of Cardiology (8) were candidates
or inclusion in this prospective study. However, only those
ith syncope of unknown origin (SUO) after an extensive
valuation were definitely included.
anagement of patients with syncope. Patients under-
ent a systematic clinical investigation including careful
istory taking (9), measurement of blood pressure in an
pright position, and an electrocardiogram. When this
orkup remained inconclusive, carotid sinus massage and
4-h Holter monitoring were performed. When this second
From the Department of Cardiology, Hôpital de la Cavale Blanche, Brest
niversity Hospital, Brest, France.p
Manuscript received July 8, 2005, revised manuscript received August 31, 2005,
ccepted September 8, 2005.ine of investigations remained negative, according to the
resence or absence of overt heart disease and/or electro-
ardiographic abnormalities, electrophysiologic study (EPS)
r HUT was performed. The alternative investigation (EPS
r HUT) was performed during the following step. Only
atients with negative baseline evaluation and negative
ubsequent test results, including EPS when necessary, were
ncluded.
rotocol of investigations. Investigations were performed
nd interpreted according to recommendations (8). Only
he protocol of the ATP test will be described in detail.
atients were investigated in the morning. The ATP and
ilt tests were successively performed, and the delay between
he two procedures was long enough to allow complete
ecovery after the first test.
TP test. Patients were advised of the likelihood of face
ushing but not of other possible side effects to avoid
xcessive emotional stress. Patients with asthma were ex-
luded. Except for drugs known to interact with ATP, the
sual treatment was continued.
Twenty milligrams of the drug was dissolved in 10 ml
aline solution and injected as a bolus. Electrocardiogram
nd blood pressure were monitored before and for 2 min
fter the injection. Patients were asked to report all of their
eelings, and they were carefully reported by the physician.
The longest recorded RR interval was measured by the
ame investigator blinded to other results. The ATP test
esult was considered positive when the maximum RR
nterval was 6 s (6). In all of our cases, the ventricular
ause resulted from atrioventricular (AV) block.
T
c
t

t
F
i
s
o
p
S
p
w
s
o
A
R
S
w
m
t
t
2
r
R
o
n
(
1
o
d
s
(
h
m
R
p
y
r
a
p
6
a
o
b
R
t
p
T
595JACC Vol. 47, No. 3, 2006 Perennes et al.
February 7, 2006:594–7 Adenosine Syncopeilt test. The protocol of HUT in our laboratory is
onventional. Its duration was planned for 45 min or until
he patient showed syncope. At the end of the 45 min, 400
g of glyceryl nitrate was administered sublingually and the
ilt period was prolonged for 20 min.
ollow-up. Every patient in whom the maximum RR
nterval measured during the ATP test exceeded four
econds was prospectively followed up. This follow-up was
btained by questionnaire or telephone interview of the
atient, his family, or the general practitioner.
tatistical analysis. The chi-square test was used to com-
are nominal parameters between the groups. Mean ages
ere compared by the Student t test. The mean number of
yncopal episodes was compared by the non-parametric test
f Mann-Whitney. The relationship between the HUT and
TP test was explored by the chi-square test.
ESULTS
tudy group. During the study period, 214 patients (119
omen) with SUO before HUT were recruited. The
ean age of the study group was 59  18 years (range, 19
Table 1. Clinical Characteristics of the Patient
Characteristics Tilt
n 9 (47.4%)
Women 7 (77.8%)
Men 2 (22.2%)
Mean age, yrs (F) 76.6  11.8
Mean age, yrs (M) 68.5  3.5
Mean number of syncope 5.33
ATP pause (s) 7.95
Mean age at first syncope 63.6  20
With prodrome 6 (66.7%)
Without prodrome 3 (33.3%)
Vagal circumstances 7 (77.8%)
No vagal circumstances 2 (22.2%)
With injury 4 (44.4%)
Without injury 5 (55.6%)
With fracture 1 (11.1%)
Without fracture 8 (88.9%)
Traffic accident 0
No traffic accident 9 (100%)
With spontaneous positive HUT
Positive NTG HUT
Vasodepressive
Cardioinhibitory
Mixed type
Unknown
Abbreviations and Acronyms
ATP  adenosine triphosphate
AV  atrioventricular
EPS  electrophysiological study
HUT  head up tilt test
SUO  syncope of unknown originATP  adenosine triphosphate; HUT  head up tilt test; NTGo 90 years). Men were slightly younger (57  17 years)
han women (61  19 years). As a consequence of syncope,
6 patients (12.1%) had a fracture and 9 patients (4.2%)
eported a traffic accident.
esults of the ATP test. A positive ATP test result was
bserved in 19 patients (8.9%), who reported a mean
umber of 4.9  2.6 (range, 2 to 15) previous episodes
Table 1). The first syncope occurred at a mean age of 64.5 
9.7 years, and they were 72.1  15.9 years old at the time
f the ATP test. The mean duration of the ventricular pause
uring ATP was 10.7  11.1 s. Women (89.5%) had this
ignificantly (p  0.0006) more frequently than men
10.5%), and the proportion of positive ATP test results was
igher in the subgroup of women than in the subgroup of
en (14.3% vs. 2.2%, p  0.002).
esults of HUT. A positive HUT was observed in 77
atients (mean age at time of first syncope, 52.2  22.1
ears, and 63.0  16.9 years at time of HUT). A positive
esponse was observed during passive HUT in 29 patients,
nd after nitrate challenge in 48 patients. The proportion of
ositive HUT was higher (p  0.03) in women (48 or
2.3%) than in men (29 or 37.7%). However, when reported
s the number of patients from each gender, the proportion
f positive HUT results was no longer significantly different
etween women (40.3%) and men (31.9%).
esults of the ATP test in patients with a negative tilt
est result. Among the 214 patients included, 77 had a
ositive HUT result, suggesting that syncope was vasovagal.
herefore, the remaining 137 patients (64%) could be
cording to the Results of ATP and Tilt Tests
ATP
Tilt Tilt Tilt
10 (52.6%) 128 (65.6%) 67 (34.4%)
10 (100%) 65 (50.8%) 38 (56.7%)
0 63 (49.2%) 29 (43.3%)
69.7  19.6 56.0  18.7 63.1  17.5
NA 56.1  18.5 60.6  14.9
4.5 4.84 4.13
13.15 1.79 2.06
65.4  19.6 47.2  18.5 50.5  21.4
6 (60%) 72 (56.2%) 42 (62.7%)
4 (40%) 56 (43.8%) 25 (37.3%)
8 (80%) 89 (69.5%) 36 (53.7%)
2 (20%) 39 (30.5%) 31 (46.3%)
3 (30%) 58 (45.3%) 29 (43.3%)
7 (70%) 70 (54.7%) 38 (56.7%)
2 (20%) 13 (10.2%) 10 (14.9%)
8 (80%) 115 (89.8%) 57 (85.1%)
0 8 (6.3%) 1 (1.5%)
10 (100%) 120 (93.7%) 66 (98.5%)
6 (60%) 23 (34.3%)
4 (40%) 44 (65.7%)
5 (50%) 42 (62.7%)
1 (10%) 8 (11.9%)
3 (30%) 15 (22.4%)
1 (10%) 2 (3.0%)s Ac
ATP nitroglycerin.
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Adenosine Syncope February 7, 2006:594–7onsidered as having SUO. The ATP test result was positive
n 9 of these 137 patients (6.6%). The mean number of
revious episodes was 5.3  2.7 (range, 2 to 15). The mean
ge of the 9 patients at time of the first syncope was 63.6 
0.9 years, and was 74.8  10.9 years at the time of ATP
est. The mean duration of ventricular pause during ATP
as 7.9  8.1 s. The number of women (7, or 77.8%) was
igher (p  0.06) than the number of men (2, or 22.2%).
hen reported as the number of patients from each gender
mong the 137 patients, the proportion of positive ATP test
esults remained higher in women (9.7% vs. 3.1%).
omparison between patients with only one positive test
esult. Results of the comparison among the 9 patients
ith only a positive ATP test result and the 67 patients with
nly a positive HUT result are listed in Table 2.
esults in patients with both test results positive. Over-
ap between the two tests was studied in the 10 patients
4.7%, all women) with both test results positive. The mean
ge at the time of the first syncope was 65.4  19.6 years
nd was 69.7  19.6 years at the time of evaluation. These
alues were not statistically different from those observed in
he nine patients with a positive ATP but a negative HUT
est result (Table 1). These 10 patients were significantly
lder (p  0.05) than the 67 patients with a negative ATP
ut positive HUT test result. It seems that patients with
ositive ATP test results had approximately the same profile
rrespective of the result of the HUT. Finally, 128 patients
59.8%) had both test results negative.
The relationship between the two tests was not signifi-
ant, but a clear trend toward a positive association (p 
.07) was observed: when the HUT result was positive (77
ases), the ATP test result was positive in 10 cases (13%),
nd when the ATP test result was positive (19 cases), the
UT result was positive in 10 patients (52.6%).
ong-term follow-up of patients with prolonged asystole
uring the ATP test. Patients with a ventricular asystole
asting four seconds or more were prospectively followed up.
he value of four seconds was chosen because a slight
ncrease in the number of patients after this cutoff point was
bserved (Fig. 1). Forty-three patients were included: 16
ad a pause lasting between 4 and 5 s, 8 between 5 and 6 s,
nd 196 s. Sixteen patients had to be excluded: 14 because
f pacemaker implantation and two because they died
pulmonary embolism and cancer). Three additional pa-
able 2. Clinical Characteristics of the Patients According to
he Results of ATP and HUT
ATP, HUT ATP, HUT p
9 67
emale 7 (77.8%) 38 (56.7%) 0.03
ean age (yrs) 74.8  10.9 62.0  16.4 0.03
ean number of syncope 5.33 4.13 NS
ean age at first syncope 63.6  20 50.1  16.4 0.07
arning symptoms 6 (66.7%) 42 (62.7%) NS
agal circumstances 7 (77.8%) 36 (53.7%) NS
ractures 1 (1.1%) 10 (14.9%) NSTP  adenosine triphosphate; HUT  head up tilt test; NS  not significant.
Iients were lost to follow-up. Finally, 24 patients were
ollowed up for a mean period of 29  13 months (range, 5
o 49 months). Recurrences of syncope were reported in 6
atients (23%): 4 had ventricular pauses between 4 and 5 s,
nd two of 7 s. Among the 8 patients with a pause6 s and
ollowed up for 31 14 months without treatment, 2 (25%)
ad recurrence of syncope.
ide effects of the ATP test. Side effects are reported in
able 3.
ehavior found in patients of the study group to ATP. Al-
ost 61% of the 214 patients had a pause2 s (Fig. 1). The
ean duration of the pause was longer (p  0.009) in
omen (3.3  5.5 s) than in men (1.9  1.5 s). Only
omen (6 patients) had pauses 10 s. No relationship
etween duration of the pause and weight, analyzed in a
ubgroup of 69 women, was found (Fig. 2).
ISCUSSION
he main result of this study is that 6.6% of patients with
UO after an extensive evaluation including HUT had a
ong ventricular pause after injection of ATP. The percent-
ge of abnormal ATP tests in patients with SUO varies
rom 41% (5), 28% (6), 15% (7), and 6.6% (present series).
his rate is decreasing regularly over time even in series
eported by the same group (6,7). Several explanations could
e found, but differences in the criteria used to define SUO
nd in the criteria used to analyze the results of the test are
igure 1. Relationship between number of patients and duration of the
entricular pause during injection of adenosine triphosphate.
able 3. Side Effects
entricular pause 30 s 2 (0.9%)
entricular pause 20 s, 30 s 3 (1.4%)
hest constriction 21 (9.8%)
ntense flush 50 (23.4%)
lush  chest constriction 49 (22.9%)
hest pain 8 (3.7%)
iffuse paresthesia 8 (3.7%)
ypotension 70 mm Hg 14 (6.5%)
ough 8 (3.7%)ntense malaise 15 (7.0%)
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February 7, 2006:594–7 Adenosine Syncoperobably the most relevant factors that explain the higher
ositive rate of ATP test reported in the first series (5,6). In
ur study, we followed recent guidelines (8) to diagnose
UO and included more than 200 patients. These argu-
ents support the fact that our proportion of patients with
positive ATP test result is probably close to the current
veryday practice. However, several questions remain un-
olved and should be answered before ATP tests gain
omplete acceptance.
s the ATP test really safe? The observed side-effects were
xpected in most instances, of short duration, completely
eversible, and not life threatening. However, induction of
ong ventricular pauses requiring limited resuscitation ma-
euvers in 1% of cases leads us to recommend the
ttendance of a physician during the test.
oes the ATP test select a “new category” of patients
ith syncope? Patients with SUO and a positive ATP test
esult were older and more frequently women than were
atients with SUO and a negative ATP test result (7,10).
hese findings were particularly evident in our study.
urthermore, we found that patients were also older at the
ime of their first syncope and that women were more
ensitive to injection of ATP (longer pauses within the
ormal range are observed in women). These demographic
ndings are of value when considering that patients with a
ositive ATP test result represent a distinctive group among
atients with syncope.
oes a positive ATP test result suggest that a spontane-
us syncope is an “ATP-sensitive” syncope? Patients
ith a positive ATP test result have a special epidemiologic
rofile, but this is only a weak argument. The reproducibil-
ty of the test is another parameter that has been studied and
eported as very good (11). However, the most powerful
rgument would be to monitor cardiac rhythm during
pontaneous syncope in patients with a positive ATP test
esult. This study has been performed in 16 patients (12).
radycardia was documented by an implantable loop re-
order during syncope in 11 patients, and 8 of them had
ong ventricular pauses, an expected result for patients with
positive ATP test result. Conversely, the five remaining
atients were free of bradycardia during syncope. Finally,
hese results remain controversial especially because patients
igure 2. Relationship between weight of 69 women and duration of the
entricular pause during injection of adenosine triphosphate.hat are the outcomes of patients with “long pauses”
uring the ATP test? This survey was not designed to
nswer this question, and the proportion of patients lost to
ollow-up is so great as to substantially bias the results.
owever, the recurrence rate of syncope seems to be
elatively low.
elationship between ATP and tilt tests. Although we
ailed to show a significant link between ATP and tilt tests,
e observed as others (7,12) an important overlap between
he tests. This does not imply that they explore the same
henomenon, but that there is probably a relationship
etween the possible common underlying phenomena.
ONCLUSIONS
njection of ATP is a safe procedure that discloses an
abnormal” behavior in approximately 7% of patients with
UO. The profile of these patients is clearly unique in that
t includes almost exclusively older women, an argument to
onsider that “ATP-sensitive” syncope could be a separate
ntity. These results are relevant to design trials to assess the
ffectiveness of therapeutic strategies.
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